Welcure Drugs & Pharmaceuticals has informed that the Board of Directors of the Company in its meeting held today, Saturday, December 06, 2025, at the registered office of the Company has reviewed and approved various decisions pertaining to the Company’s past business operations and investment-related matters- Execution of Letter of Intent (LOI) with Telexcell Trade PTE LTD, Singapore for Equity Investment; Proposed Agro-Pharma Research Laboratory & Board Meeting held on 28 August 2025 to consider fund-raising by QIP.
The above information is a part of company’s filings submitted to BSE.